Combination Treatment for Visceral Leishmaniasis Patients Coinfected with Human Immunodeficiency Virus in India

Combination Treatment for Visceral Leishmaniasis Patients Coinfected with Human Immunodeficiency Virus in India

We describe the safety and efficacy of treating visceral leishmaniasis (VL) in patients with human immunodeficiency virus-VL coinfection with concurrent intravenous liposomal amphotericin B (AmBisome) and oral miltefosine (Impavido) in India. The regimen was safe, well tolerated, with lower relapse...

Full description

Bibliographic Details
Main Authors: Mahajan, Raman, Das, Pradeep, Isaakidis, Petros, Sunyoto, Temmy, Sagili, Karuna D, Lima, Marıa Angeles, Mitra, Gaurab, Kumar, Deepak, Pandey, Krishna, Van geertruyden, Jean-Pierre, Boelaert, Marleen, Burza, Sakib
Format: Online
Language:English
Published: Oxford University Press 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4583582/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4583582/

Similar Items